Articles by Jennifer Markarian - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jennifer Markarian

The Foundation for the National Institute of Health Seeks Public Comment

Aug 28, 2012

The Observational Medical Outcomes Partnership (OMOP), which is managed by the Foundation, desires feedback on proposed research priorities and tasks.

Pfizer's Zoetis Subsidiary Files IPO

Aug 14, 2012

Zoetis, a subsidiary of Pfizer, filed a registration statement with the US Securities and Exchange Commission for a potential initial public offering (IPO) of Class A common stock.

Second-Quarter 2012 Financial Reports Show Pfizer, Novartis Down; Merck Up

Jul 31, 2012

Pharmaceutical industry leaders Pfizer, Novartis, and Merck—among others—released second-quarter 2012 results, emphasizing growth of new products and strength in emerging markets.

IMS Institute for Healthcare Informatics Issues Forecast for Global Medicine Use

Jul 16, 2012

Global spending on medicines is estimated to reach nearly $1.2 trillion by 2016.

ISPE Issues Guidance for Packaging, Labeling, and Warehousing Facilities

Jul 9, 2012

Guide helps companies meet CGMP requirements.

Teva Wins Patent-infringement Lawsuit Protecting Copaxone

Jun 25, 2012

US court ruled in favor of Teva in its patent-infringement lawsuit against Momenta and Mylan's generic versions of Teva's Copaxone.

Pharma Associations Provide Update on Anticounterfeiting Initiatives

Jun 11, 2012

European and US associations call for continued vigilance against the threat of counterfeit medicines.

Human Genome Sciences Rejects GlaxoSmithKline's $2.6 Billion Offer

May 21, 2012

Human Genome Sciences rejects GlaxoSmithKline offer to acquire the company and issues a poison pill to prevent a takeover.

FDA Issues Guidance for Industry Direct-to-Consumer Television Advertisements

Mar 20, 2012

On Mar. 12, 2012, FDA released a draft guidance document for industry direct-to-consumer (DTC) television advertisements that describes FDA?s plans for implementing predissemination review.

ADVERTISEMENT

ADVERTISEMENT

Click here